Item Type | Name |
Concept
|
Medicine, Chinese Traditional
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
Concept
|
Hot Temperature
|
Concept
|
Long-Term Care
|
Concept
|
Triglycerides
|
Concept
|
Glucose Transporter Type 4
|
Concept
|
Cell Death
|
Concept
|
Tetrazolium Salts
|
Concept
|
Transcription Factor AP-1
|
Concept
|
Neutralization Tests
|
Concept
|
Thiocyanates
|
Concept
|
Liver Transplantation
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Cell Transdifferentiation
|
Concept
|
tert-Butylhydroperoxide
|
Concept
|
Transduction, Genetic
|
Concept
|
Protein Tyrosine Phosphatases
|
Concept
|
beta-Thalassemia
|
Concept
|
Liver Function Tests
|
Concept
|
Genetic Testing
|
Concept
|
Combined Modality Therapy
|
Concept
|
Thrombocytopenia
|
Concept
|
Receptors, Transferrin
|
Concept
|
Interviews as Topic
|
Concept
|
Thiazolidinediones
|
Concept
|
Immunologic Tests
|
Concept
|
Trans-Activators
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Magnetic Field Therapy
|
Concept
|
Patient Education as Topic
|
Concept
|
Endothelial Cells
|
Concept
|
Cell Respiration
|
Concept
|
Tin
|
Concept
|
3T3 Cells
|
Concept
|
Thiophenes
|
Concept
|
Triazoles
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Genetic Techniques
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Cell Line, Transformed
|
Concept
|
Bone Marrow Cells
|
Concept
|
Immunoenzyme Techniques
|
Concept
|
Hep G2 Cells
|
Concept
|
Biological Transport, Active
|
Concept
|
Transcription, Genetic
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Tryptophan
|
Concept
|
Diabetes Mellitus, Type 2
|
Concept
|
Treatment Failure
|
Concept
|
Cell Fractionation
|
Concept
|
ZAP-70 Protein-Tyrosine Kinase
|
Concept
|
Transferrin
|
Concept
|
Cells, Cultured
|
Concept
|
Alanine Transaminase
|
Concept
|
Transaminases
|
Concept
|
T-Lymphocytes
|
Concept
|
Tetrapyrroles
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Signal Transduction
|
Concept
|
Cell Proliferation
|
Concept
|
Time Factors
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Tissue Distribution
|
Concept
|
Tandem Mass Spectrometry
|
Concept
|
Epithelial Cells
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Protein Transport
|
Concept
|
Terpenes
|
Concept
|
Thiazoles
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Taq Polymerase
|
Concept
|
Terminology as Topic
|
Concept
|
Tissue Inhibitor of Metalloproteinase-1
|
Concept
|
Protein Processing, Post-Translational
|
Concept
|
Cytotoxicity Tests, Immunologic
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
Tricuspid Valve Insufficiency
|
Concept
|
Cell Nucleus
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Telomere
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
Concept
|
Cell Survival
|
Concept
|
Kupffer Cells
|
Concept
|
Treatment Outcome
|
Concept
|
Calcium Channels, T-Type
|
Concept
|
Tryptophan Oxygenase
|
Concept
|
Bone Marrow Transplantation
|
Concept
|
TATA Box
|
Concept
|
Transcription Factors
|
Concept
|
Predictive Value of Tests
|
Concept
|
Electron Transport
|
Concept
|
Basic-Leucine Zipper Transcription Factors
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Tetanus Toxin
|
Concept
|
Cell Line
|
Concept
|
Cell Compartmentation
|
Concept
|
STAT1 Transcription Factor
|
Concept
|
Transfection
|
Concept
|
STAT2 Transcription Factor
|
Concept
|
Cell Extracts
|
Concept
|
Tea
|
Concept
|
Receptors, Tumor Necrosis Factor
|
Concept
|
Hepatic Stellate Cells
|
Concept
|
Porphyria Cutanea Tarda
|
Concept
|
Tangier Disease
|
Concept
|
Directly Observed Therapy
|
Concept
|
Cation Transport Proteins
|
Concept
|
Templates, Genetic
|
Concept
|
Killer Cells, Natural
|
Concept
|
Interferon Type I
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Cell Line, Tumor
|
Concept
|
Congresses as Topic
|
Concept
|
Rats, Transgenic
|
Academic Article
|
Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh).
|
Academic Article
|
Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
|
Academic Article
|
Iron and the liver.
|
Academic Article
|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
|
Academic Article
|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition.
|
Academic Article
|
Synergistic induction of delta-aminolevulinate synthase by glutethimide and iron: relationship to the synergistic induction of heme oxygenase.
|
Academic Article
|
Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
|
Academic Article
|
Mechanism of synergistic induction of hepatic heme oxygenase by glutethimide and iron: studies in cultured chick embryo liver cells.
|
Academic Article
|
Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
|
Academic Article
|
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
|
Academic Article
|
Choline may be an essential nutrient in malnourished patients with cirrhosis.
|
Academic Article
|
Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
|
Academic Article
|
Heme catabolism in cultured hepatocytes: evidence that heme oxygenase is the predominant pathway and that a proportion of synthesized heme is converted rapidly to biliverdin.
|
Academic Article
|
Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
|
Academic Article
|
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
|
Academic Article
|
Immunochemical detection of different isoenzymes of cytochrome P-450 induced in chick hepatocyte cultures.
|
Academic Article
|
Hepatic microsomal function in rats with chronic dietary iron overload.
|
Academic Article
|
Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide.
|
Academic Article
|
Regulation of hepatic haem metabolism. Disparate mechanisms of induction of haem oxygenase by drugs and metals.
|
Academic Article
|
Tryptophan 2,3-dioxygenase in chick embryo hepatocytes: studies in ovo and in culture.
|
Academic Article
|
Haem synthesis from exogenous 5-aminolaevulinate in cultured chick-embryo hepatocytes. Effects of inducers of cytochromes P-450.
|
Academic Article
|
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.
|
Academic Article
|
Induction of porphyria in cultured chick-embryo hepatocytes by halogenated aromatic compounds.
|
Academic Article
|
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials.
|
Academic Article
|
Induction of 5-aminolaevulinate synthase by two- to five-carbon alcohols in cultured chick-embryo hepatocytes. Relationship to induction of cytochrome P-450.
|
Academic Article
|
Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital.
|
Academic Article
|
Increased glutathione in cultured hepatocytes associated with induction of cytochrome P-450. Lack of effect of glutathione depletion on induction of cytochrome P-450 and delta-aminolevulinate synthase.
|
Academic Article
|
Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448.
|
Academic Article
|
Formation of cytochrome P-450 containing haem or cobalt-protoporphyrin in liver homogenates of rats treated with phenobarbital and allylisopropylacetamide.
|
Academic Article
|
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
|
Academic Article
|
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
|
Academic Article
|
Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease.
|
Academic Article
|
Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.
|
Academic Article
|
Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria.
|
Academic Article
|
Repression of ALA synthase by heme and zinc-mesoporphyrin in a chick embryo liver cell culture model of acute porphyria.
|
Academic Article
|
Colonic mucosal appearance of Tangier disease in a new patient.
|
Academic Article
|
The post-translational processing of myeloperoxidase is regulated by the availability of heme.
|
Academic Article
|
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.
|
Academic Article
|
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytes.
|
Academic Article
|
Inflammatory cloacogenic polyp: three cases and literature review.
|
Academic Article
|
Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.
|
Academic Article
|
Induction of heme oxygenase in intestinal epithelial cells: studies in Caco-2 cell cultures.
|
Academic Article
|
3,5,5-Trimethylhexanoylferrocene induction of heme oxygenase activity in normal hepatocytes.
|
Academic Article
|
Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature.
|
Academic Article
|
Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: relationship to inhibition of heme oxygenase.
|
Academic Article
|
Advances in understanding and treating 'the little imitator,' acute porphyria.
|
Academic Article
|
Purifying nascent mRNA from nuclear run-on assays using guanidinium isothiocyanate.
|
Academic Article
|
Molecular basis for heme-dependent induction of heme oxygenase in primary cultures of chick embryo hepatocytes. Demonstration of acquired refractoriness to heme.
|
Academic Article
|
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
|
Academic Article
|
Induction of heme oxygenase-1 in LMH cells. Comparison of LMH cells to primary cultures of chick embryo liver cells.
|
Academic Article
|
Effect of interferon therapy on bile duct inflammation in hepatitis C.
|
Academic Article
|
An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.
|
Academic Article
|
Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins.
|
Academic Article
|
Regulation of metallothionein gene expression. Studies in transfected primary cultures of chick embryo liver cells.
|
Academic Article
|
Haemopexin and uptake of haem by liver cells.
|
Academic Article
|
Iron and chronic viral hepatitis.
|
Academic Article
|
Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response.
|
Academic Article
|
Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.
|
Academic Article
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures.
|
Academic Article
|
Therapy of hepatitis C: other options.
|
Academic Article
|
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
|
Academic Article
|
Inflammatory markers in chronic hepatitis C.
|
Academic Article
|
Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases.
|
Academic Article
|
Molecular cloning, characterization, and expression of the chicken heme oxygenase-1 gene in transfected primary cultures of chick embryo liver cells.
|
Academic Article
|
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.
|
Academic Article
|
Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases.
|
Academic Article
|
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
|
Academic Article
|
Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
|
Academic Article
|
Porphyrin loading of lipofuscin granules in inflamed striated muscle.
|
Academic Article
|
Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
|
Academic Article
|
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
|
Academic Article
|
The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria.
|
Academic Article
|
Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats.
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
Academic Article
|
Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria.
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
Academic Article
|
IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
|
Academic Article
|
Heme biosynthesis in a chicken hepatoma cell line (LMH): comparison with primary chick embryo liver cells (CELC).
|
Academic Article
|
Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells.
|
Academic Article
|
Effects of phenylarsine oxide on expression of heme oxygenase-1 reporter constructs in transiently transfected cultures of chick embryo liver cells.
|
Academic Article
|
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
|
Academic Article
|
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
|
Academic Article
|
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
|
Academic Article
|
Induction of the heme oxygenase-1 gene by metalloporphyrins.
|
Academic Article
|
Outcomes research in chronic viral hepatitis C: effects of interferon therapy.
|
Academic Article
|
Upstream regulatory elements in chick heme oxygenase-1 promoter: a study in primary cultures of chick embryo liver cells.
|
Academic Article
|
Management of recurrent hepatitis C after liver transplantation: a concise review.
|
Academic Article
|
Hepatitis C: a review and update.
|
Academic Article
|
Hepatic iron concentration and total body iron stores in thalassemia major.
|
Academic Article
|
Iron-induced liver injury.
|
Academic Article
|
Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
|
Academic Article
|
Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells.
|
Academic Article
|
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
|
Academic Article
|
Extrahepatic manifestations of infection with hepatitis C virus.
|
Academic Article
|
Induction of heme oxygenase-1 by phenylarsine oxide. Studies in cultured primary liver cells.
|
Academic Article
|
Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation.
|
Academic Article
|
Mapping of the chick heme oxygenase-1 proximal promoter for responsiveness to metalloporphyrins.
|
Academic Article
|
Intestinal expression of genes involved in iron absorption in humans.
|
Academic Article
|
Hemochromatosis and porphyria.
|
Academic Article
|
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
|
Academic Article
|
Management of nonalcoholic steatohepatitis: an analytic review.
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
Academic Article
|
Optimal management of nonalcoholic fatty liver/steatohepatitis.
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
Academic Article
|
Identification of key elements that are responsible for heme-mediated induction of the avian heme oxygenase-1 gene.
|
Academic Article
|
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
|
Academic Article
|
Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS.
|
Academic Article
|
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
|
Academic Article
|
Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
|
Academic Article
|
Recommendations for the diagnosis and treatment of the acute porphyrias.
|
Academic Article
|
Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
|
Academic Article
|
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis.
|
Academic Article
|
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
|
Academic Article
|
Haem repression of the housekeeping 5-aminolaevulinic acid synthase gene in the hepatoma cell line LMH.
|
Academic Article
|
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
|
Academic Article
|
Iron in nonhemochromatotic liver disorders.
|
Academic Article
|
Liver transplantation for erythropoietic protoporphyria liver disease.
|
Academic Article
|
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).
|
Academic Article
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
Academic Article
|
HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
|
Academic Article
|
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
Academic Article
|
Autoimmune hepatitis triggered by statins.
|
Academic Article
|
Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin.
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
Academic Article
|
Genetic aspects of porphyria cutanea tarda.
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia.
|
Academic Article
|
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
|
Academic Article
|
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
|
Academic Article
|
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
|
Academic Article
|
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
|
Academic Article
|
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
|
Academic Article
|
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
|
Academic Article
|
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
|
Academic Article
|
Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.
|
Academic Article
|
Tissue-specific expression of ALA synthase-1 and heme oxygenase-1 and their expression in livers of rats chronically exposed to ethanol.
|
Academic Article
|
Case records of the Massachusetts General Hospital. Case 20-2008. A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery.
|
Academic Article
|
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
|
Academic Article
|
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
|
Academic Article
|
Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells.
|
Academic Article
|
Hereditary hemochromatosis: time for targeted screening.
|
Academic Article
|
Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
Academic Article
|
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
Academic Article
|
The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondria.
|
Academic Article
|
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
Academic Article
|
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
|
Academic Article
|
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
|
Academic Article
|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
|
Academic Article
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
Academic Article
|
Drug-induced liver injury associated with statins.
|
Academic Article
|
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
|
Academic Article
|
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
Academic Article
|
Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
Academic Article
|
Genetic variations in heme oxygenase-1 and chronic hepatitis.
|
Academic Article
|
A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.
|
Academic Article
|
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
Academic Article
|
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
|
Academic Article
|
Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
|
Academic Article
|
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
|
Academic Article
|
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
|
Academic Article
|
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
|
Academic Article
|
Effect of bovine serum albumin on mitochondrial respiration in the brain and liver of mice and rats.
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
Academic Article
|
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
|
Academic Article
|
Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology.
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
Academic Article
|
Structural analysis of heme proteins: implications for design and prediction.
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
Academic Article
|
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
Academic Article
|
Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene.
|
Academic Article
|
An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
|
Academic Article
|
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
|
Academic Article
|
Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes.
|
Academic Article
|
Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method.
|
Academic Article
|
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
|
Academic Article
|
Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
|
Academic Article
|
The diagnosis and management of erythropoietic protoporphyria.
|
Academic Article
|
A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
Academic Article
|
Serum proteomic profiling in patients with drug-induced liver injury.
|
Academic Article
|
Chinese medicine for treatment of chronic hepatitis B.
|
Academic Article
|
Hepatitis C, porphyria cutanea tarda and liver iron: an update.
|
Academic Article
|
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
|
Academic Article
|
The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes.
|
Academic Article
|
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
|
Academic Article
|
DNA methylation patterns in alcoholics and family controls.
|
Academic Article
|
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
|
Academic Article
|
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
|
Academic Article
|
Risk factors for porphyria cutanea tarda -the iron/HFE connection.
|
Academic Article
|
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
|
Academic Article
|
Liver injury from tumor necrosis factor-a antagonists: analysis of thirty-four cases.
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
Academic Article
|
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
|
Academic Article
|
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.
|
Academic Article
|
Heme status affects human hepatic messenger RNA and microRNA expression.
|
Academic Article
|
Porphyrin and heme metabolism and the porphyrias.
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
Academic Article
|
Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer.
|
Academic Article
|
Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
|
Academic Article
|
Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
|
Academic Article
|
Novel role of nuclear receptor Rev-erba in hepatic stellate cell activation: potential therapeutic target for liver injury.
|
Academic Article
|
Hepatotoxicity of anti-TNF agents.
|
Academic Article
|
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
|
Academic Article
|
Statins and liver injury.
|
Academic Article
|
Indications for liver transplant and AASLD guidelines.
|
Academic Article
|
Drug-induced liver injury with autoimmune features.
|
Academic Article
|
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
|
Academic Article
|
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
|
Academic Article
|
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
|
Academic Article
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
|
Academic Article
|
Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
|
Academic Article
|
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
|
Academic Article
|
Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
|
Academic Article
|
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
|
Academic Article
|
Hepatotoxicity Associated with the Use of Anti-TNF-a Agents.
|
Academic Article
|
Amoxicillin-Clavulanate-Induced Liver Injury.
|
Academic Article
|
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.
|
Academic Article
|
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
|
Academic Article
|
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
|
Academic Article
|
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
|
Academic Article
|
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
|
Grant
|
Research Network for Drug-Induced Liver Disease
|
Grant
|
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
|
Grant
|
Regulation of Hepatic Heme Metabolism
|
Grant
|
HEPATIC HEME, CYTOCHROME P-450 AND DRUG METABOLISM
|
Grant
|
Effect of Heme on mRNA and miRNA Profile
|
Academic Article
|
Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
|
Academic Article
|
Porphyria.
|
Academic Article
|
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
Academic Article
|
Porphyria.
|
Academic Article
|
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx.
|
Academic Article
|
Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.
|
Academic Article
|
Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
Academic Article
|
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias.
|
Academic Article
|
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
|
Academic Article
|
Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
|
Academic Article
|
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
|
Academic Article
|
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
|
Academic Article
|
Benefits of prophylactic heme therapy in severe acute intermittent porphyria.
|